BIOGEN INC. Available-for-sale Securities
BIOGEN INC. (BIIB) had Available-for-sale Securities of $2.22 billion as of 2021-06-30, per its 10-Q filed 2021-07-22.
Discontinued › Notes › Investments
us-gaap:AvailableForSaleSecurities · last filed 2021-07-22
- 2021-06-30: Available-for-sale Securities $2.22B.
- 2021-03-31: Available-for-sale Securities $2.14B.
- 2020-12-31: Available-for-sale Securities $2.05B.
- 2020-09-30: Available-for-sale Securities $2.36B.
| Period end | Available-for-sale Securities |
|---|---|
| 2021-06-30 | $2.22B 10-Q · filed 2021-07-22 |
| 2021-03-31 | $2.14B 10-Q · filed 2021-04-22 |
| 2020-12-31 | $2.05B 10-Q · filed 2021-07-22 |
| 2020-09-30 | $2.36B 10-Q · filed 2020-10-21 |
| 2020-06-30 | $2.87B 10-Q · filed 2020-07-22 |
| 2020-03-31 | $2.24B 10-Q · filed 2020-04-23 |
| 2019-12-31 | $2.97B 10-Q · filed 2020-10-21 |
| 2019-09-30 | $3.91B 10-Q · filed 2019-10-22 |
| 2019-06-30 | $2.54B 10-Q · filed 2019-07-24 |
| 2019-03-31 | $3.04B 10-Q · filed 2019-04-24 |
| 2018-12-31 | $3.69B 10-Q · filed 2019-10-22 |
| 2018-03-31 | $3.01B 10-Q · filed 2018-04-24 |
| 2017-12-31 | $5.17B 10-K · filed 2019-02-06 |
| 2017-09-30 | $5.02B 10-Q · filed 2017-10-24 |
| 2017-06-30 | $4.36B 10-Q · filed 2017-07-25 |
| 2017-03-31 | $4.78B 10-Q · filed 2017-04-25 |
| 2016-12-31 | $5.40B 10-K · filed 2018-02-01 |
| 2016-09-30 | $5.33B 10-Q · filed 2016-10-26 |
| 2016-06-30 | $5.91B 10-Q · filed 2016-07-21 |
| 2016-03-31 | $5.64B 10-Q · filed 2016-04-21 |
| 2015-12-31 | $4.88B 10-K · filed 2017-02-02 |
| 2015-09-30 | $3.70B 10-Q · filed 2015-10-21 |
| 2015-06-30 | $3.19B 10-Q · filed 2015-07-24 |
| 2015-03-31 | $2.05B 10-Q · filed 2015-04-24 |
| 2014-12-31 | $2.11B 10-K · filed 2016-02-03 |
| 2014-09-30 | $2.05B 10-Q · filed 2014-10-22 |
| 2014-06-30 | $1.72B 10-Q · filed 2014-07-23 |
| 2014-03-31 | $1.16B 10-Q · filed 2014-04-23 |
| 2013-12-31 | $1.25B 10-K · filed 2015-02-04 |
| 2013-09-30 | $614.40M 10-Q · filed 2013-10-28 |
| 2013-06-30 | $382.30M 10-Q · filed 2013-07-25 |
| 2012-12-31 | $3.17B 10-K · filed 2014-02-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |